Saltar al contenido
Merck

Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.

The Journal of physiology (2017-08-18)
Adrianne R Wilson-Poe, Hyo-Jin Jeong, Christopher W Vaughan
RESUMEN

Chronic treatment with opioids, such as morphine, leads to analgesic tolerance. While postsynaptic opioid tolerance is well documented, the involvement of presynaptic mechanisms remains unclear. We show that chronic morphine reduces the ability of periaqueductal grey (PAG) neurons to maintain GABAergic transmission. This depression of GABAergic transmission was due to a reduction in the effective size of the readily releasable pool. This also led to a reduction in opioid presynaptic inhibition; these presynaptic adaptations need to be considered in the development of strategies to reduce opioid tolerance. The midbrain periaqueductal grey (PAG) plays a critical role in tolerance to the analgesic actions of opioids such as morphine. While numerous studies have identified the postsynaptic adaptations induced by chronic morphine treatment in this and other brain regions, the presence of presynaptic adaptations remains uncertain. We examined GABAergic synaptic transmission within rat PAG brain slices from animals which underwent a low dose morphine treatment protocol which produces tolerance, but not withdrawal. Evoked GABAergic IPSCs (inhibitory postsynaptic currents) were less in morphine compared to control saline treated animals. Postsynaptic GABA

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
[D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin acetate salt, ≥97% (HPLC)
Sigma-Aldrich
DL-Propargylglycine, cystathionine γ-lyase inhibitor
Sigma-Aldrich
8-Cyclopentyl-1,3-dipropylxanthine, solid
Sigma-Aldrich
CNQX, ≥98% (HPLC), solid
Sigma-Aldrich
Strychnine hydrochloride
Sigma-Aldrich
AM251, >98% (HPLC), solid